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Lactation and other clinical states ofhigh bone tumover have been su to release lead (Pb)
stored in bone into blood and tissues. Previous observations on the influenes oflactation have
been anecdotal, or at high blood Pb concentrations with varing past expos or complicated
bypostpartum fluid changes. A prospecve observational studywasperformed to investigate pos-
sible changes in blood lead concentrations at multiple intervals during lactation for 6 months
postpartum and to relate changes in blood lead concentraions to anges in bone density and
othervariables. Volunteerpregnantsubjects (n m 58) wereenrolled from a midwiferysemceatan
academic publichealthhospital. Subjects were mostly Hispanic, recently immigrad, oflow eco
nomic status, not receiving supplemental calcium, andhad low blood Pb concentaions (2.35 ±
2.05 pgldl at enrollment). Bone density losses over 6 months for the grup averaged -2.46 *
6.33% atthevertebnlspineand-0.67 ± 5.21% atthe femoralneck Inpredictingfinal boneden-
sity, apart from initial bone density only the total number ofbreast-feedings was a significant
independenlt variable ofthe variables tested, accounting for an additional 12% ofthe variability.
No chnges in blood Pb concentamions were soen over the interval beyond 2 weeks postpartum
(niinimum detectablechange was 0.4pgdl). Therewas no relationbetween the changes in bone
density andchanges in blood Pb or the tat blood Pb over the 2-wek to 6-month period.
Normal (nonlating) bone resorption rates contributealarge fraction ofthe Pb in blood during
low-posure circumstances. However, during lctation the increase in bone resorpive processes
is probably relatively small with a lrer decrea in diion accounng for net bone loss, as
suggested by other insiion Thus, concomitant release ofPb from bones oflactating sub-
jects with low blood lead concentraton on this bacound ofhigh normal resorption was not
larg enough for detecton. Igy wonrd blood lead, bone density, lactation, Pb. Environ Heabl
Penpect107:187-194 (1999). [Online 26January 19991
btp.//ehpnetl.niehs.nih.gov/docs /1999/107p187-l940osmkah/abstractmd
Greater than 90% ofthe metal lead (Pb) in
the adult human body is stored in the bone
(1). The equilibria between bone and other
tissues greatly favors bone as a sink (2,3),
but even the small rate of Pb released back
to tissues from the large bone compartment
may contribute significantly to the tissue or
blood concentrations (bone concentrations
are approximately 100-200-fold greater
than blood). Using the natural isotopic sig-
natures of endogenous Pb, we have previ-
ously shown that for individuals with nor-
mal background exposure to Pb, approxi-
mately 60% of Pb in the blood is derived
from earlier deposited Pb in bone stores (4).
Pathologic and physiologic states such as
hyperparathyroidism, pregnancy, lactation,
and osteoporosis have been suggested to
mobilize Pb from bone storage (5-8).
Isolated observations in several individuals
with high past Pb exposure have shown
increases in blood Pb concentration thought
to be due to clinical states ofincreased bone
turnover (9-12). Longitudinal studies are
being performed to examine the influences
ofosteoporosis and pregnancy more closely.
Decreases in bone density of 0-5%
during lactation have been clearly docu-
mented by several investigations using x-ray
densitometry, particularly when lactation
exceeds 5-6 months (13). With the mobi-
lization of calcium during lactation, Pb
mobilization might also be expected. In a
recent cross-sectional study ofbone Pb con-
centrations in a normally exposed popula-
tion measured by K-shell x-ray fluorescence,
age and sex were the most important predic-
tors in modeling the accumulation ofPb in
bone. However, lactation history was also a
weak inverse predictor in females of the
sampled population (14). Potential increases
in blood Pb concentrations during lactation
might roughly be predicted from measure-
ments ofbone Pb concentrations, the parti-
tioning of released Pb between the blood
and various tissue pools, and the amount
of bone loss measured during lactation.
Limiting knowledge includes the precise
dynamic partitioning of lead in blood and
tissues, poor information on whether Pb is
released from bone in a manner similar to
calcium (may be less soluble to osteoclastic
influences), whether Pb is redeposited back
into bone from the fractions previously
released, and othervariables.
Only one study has attempted to assess
changes in blood Pb concentrations during
lactation in humans (15). In this study only
a small portion ofthe subjects were actually
breast-feeding and for only short durations.
In addition, changes in bone density were
not measured and initial baseline blood Pb
concentrations were confounded by acute
peripartum changes in fluid volumes. To
address the concern that lactation may mobi-
lize lead, thereby possibly increasing harmful
tissue levels, we have undertaken a longitudi-
nal study of a relatively uniform cohort of
lactating women who were not receiving cal-
cium supplementation, assessed with mea-
surements ofbreast-feeding frequency, serial
blood Pb concentrations, and validation of
bone loss bydual-energy bone densitometry.
Materials and Methods
Settinganddesign. This study tookplace at
San Francisco General Hospital through the
Nurse Midwifery Service (NMS) from June
1994 to May 1996. Study protocol and con-
sent procedures were approved by the
University of California Committee on
Human Research. The studydesign was that
of a prospective cohort with measurements
of breast-feeding frequency and blood Pb
concentrations at 2-3 weeks prior to deliv-
ery, at birth, and at 2 weeks, 6 weeks, 3
months, and 6 months after delivery. Bone
densitometry was measured at delivery and
at 6 months. Bone marker measurements
were made at 2 weeks and 6 months after
delivery. The major outcome was the rela-
tionship between the change in blood Pb
concentrations over the 2-week (or 6-week)
to 6-month postdelivery interval and the
change in bone densities at vertebral and
femoral neck sites. Uncomplicated pregnan-
cies followed during prenatal visits in the
NMS were the source ofthe subject popula-
tion. This service performs approximately
600 assisted hospital deliveries/year and
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serves a surrounding community of low
income, primarily Hispanic people, most of
whom are uninsured and qualify for the
Well Infant Child care program (annual
household income <$17,500/year).
Enrollment andprotocol. Pregnant
patients receiving prenatal care were given
preliminary information about the study in
the form of a study announcement distrib-
uted by the Certified Nurse Midwives
(CNM) or the research assistant during pre-
natal visits. A few subjects were referred
from the Obstetrical Service, given the pre-
liminary announcement, and thereafter
treated as NMS patients. In addition, the
study announcement was posted on clinic
doors and in waiting areas. Those contact-
ing the research assistant at the time ofthe
initial contact or via phone were scheduled
at 32-38 weeks ofgestation for an explana-
tory meeting and given the informed con-
sent form to review. Those consenting
immediately and those consenting after
rescheduling were interviewed for medical,
dietary, social, and breast-feeding histories.
Blood samples were also obtained at this
time for blood Pb, hemoglobin, serum
albumin, and iron concentrations. Clinic
charts on these subjects were reviewed with-
in the week after the interview for specified
medical data and compared for consistency
with medical interview information. All
interview responses and chart information
were entered directly into a laptop comput-
er after the research assistant verbally read
each prompted question. After this inter-
view and as an overall educational effort by
the NMS to encourage breast-feeding, all
clinic clientele were given brochures and
viewed a videotape on proper breast-feed-
ing. All information, consent forms, and
interview questions were developed and
provided in Spanish or English.
Inclusion/exclusion criteria applied
during the initial interview process were as
follows: all subjects must be pregnant,
18-40 years of age, and in generally good
health. Subjects with a history or treatment
of any serious acute or chronic disease,
including but not limited to congestive
heart failure, insulin-dependent diabetes,
renal insufficiency, metabolic bone disease,
or endocrine problems, were not eligible.
Pregnant women with underlying diseases
or anticipated complications of pregnancy
were not admitted to the NMS. Testing for
conditions prevalent in this hospital popu-
lation, such as hepatitis B, human immun-
odeficiency virus positivity, or intravenous
drug abuse, were not performed, although
subjects were excluded if they gave a
positive history. All potential continuing
subjects must have had at least one prior
prenatal visit.
Prenatal charts were flagged with
instructions to obtain blood tests and alert
the research assistant when the subject was
admitted for delivery. Within 1-2 days of
delivery, further specified data regarding
delivery complications, maternal and infant
weights, and a hospital nutritionist evalua-
tion were obtained from the peripartum
chart. A portion of the earlier interview on
breast-feeding variables was repeated at this
time and bone densities at femoral neck and
vertebral sites were performed. Interviews to
obtain continuing information on breast-
feeding variables and blood sampling were
repeated again at 2 weeks, 6 weeks, 3
months, and 6 months. In addition, the 6-
month interview included repeated dietary
and medical evaluations, a pregnancy test,
and the second bone density determination.
All subjects were scheduled for inter-
views at the beginning ofthe study with fol-
low-up tracking and reminder phone calls
made prior to scheduled visits. Nearly all of
the 1,007 patients seen by the NMS during
the enrollment period had viewed the post-
ed announcement or were approached by
the CNM or research assistant. One hun-
dred forty-five potentially interested subjects
were read the consent form and 120 ofthese
enrolled. Those not enrolling cited lack of
time, fear of blood drawing, and partner
opposition as reasons. Ofthe 120 enrollees,
58 completed the entire study, 19 discontin-
ued the study before the first or second
interview, and 43 finished the study but
missed multiple or critical scheduled dates
(incompletes). Ofthe total 62 not complet-
ing or discontinuing the study, reasons cited
for noncompletion were enrollee relocation
(n = 6), partner opposition (n = 1), fear of
blood drawing (n = 6), time conflicts (n =
3), infant death (n = 1), no reason given (n =
5), and the remainder were due to missed
appointments.
Questionnaire and chart informa-
tion. A goal in this study was to obtain a
more precise measure of breast-feeding
than in a model lactation study (13), where
only the time to discontinuation of breast-
feeding was recorded. The reason for this
was to demonstrate the validity of this
model in our application, i.e., that bone
loss had actually occurred and was related
to breast-feeding. Measures of breast-feed-
ing frequency (total number ofbreast-feed-
ings) were computed from the number of
breast-feedings recalled for each interval
during the day, at night, and the estimated
ounces and number of breast pumpings
performed. Time to the discontinuation of
breast-feeding and the number of bottle
feedings were also recorded.
Other variables obtained from the ques-
tionnaire or medical charts were gathered to
address the medical exclusionary criteria
and to obtain other independent variables
that might impact either the breast-feed-
ing-bone loss relationship or the major out-
come relationship of whether bone loss is
associated with changes in blood Pb (Table
1). In addition, four composite variables
were computed: socioeconomic rating,
health rating, calcium intake rating, and
dietary quality rating. Each composite vari-
able was an attempt to rank order or stratify
the subjects within the narrow variation of
this cohort. Socioeconomic rating was com-
puted by averaging the five z scores of the
following variables: 1) the number of adults
working divided by the number of adults
and children in the home; 2) the number of
rooms divided by the number ofadults and
children in the home; 3) the monthly rent
divided by the number of adults and chil-
dren in the home; 4) the number ofyears of
education ofthe subjects; and 5) the number
of years living in the United States [as par-
tially adapted from Centerwall (16)] (171.
The health rating was calculated by averag-
ing the two z scores of the following vari-
ables: the number oflifetime illnesses (more
serious than colds, flu, and common child-
hood illnesses) added to the number of
minor illnesses during the current pregnancy;
and the number of times that the serum
albumin and iron concentrations were out-
side the relevant reference range during the
6-week, 3-month, and 6-month visits.
Calcium intake and dietary quality ratings
were not based on explicit food frequency
inventories. Dietary quality ratings resulted
from scoring interview questions covering
the number ofmeals and snacks, foods most
liked, and milk and fast-food consumption.
Calcium ratings were weighted toward dairy
product consumption because milk ingestion
predicts 80% of the variability of calcium
intake and ratings included amounts ofmilk
ingested and foods most consumed (18-20).
Bone density measurements. The dual-
energy x-ray absorption measurements made
within 1 day of delivery and at 6 months
postdelivery were performed on a Lunar
DPX dual-energy x-ray densitometer (Lunar
Corp., Madison, WI) in accordance with the
manufacturer's instructions and after certifi-
cation training of our research technician
(21). The instrument utilizes an x-ray tube
source with a cerium filter producing two x-
ray energies of 38 and 70 keV, and a sodi-
um-iodide crystal photomultiplier detector.
The x-ray tube was operated at 76 kV and
750 pA and collimated to 1.68 mm. The
exposure per scan was 1.2 mR (22). Bone
density (in grams per square centimeter) was
measured at the right femoral neck and the
vertebral lumbar spine (average of L2-L4).
Subject positioning was standardized. For
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the anterior-posterior scan ofthe spine, the
subject was placed in a supine position with
the legs flexed at the knees; for the anterior-
posterior scan of the hip, the subject was
supine with the hip internally rotated and
braced at the foot. Calibration checks and
quality control phantoms were performed
with each day of use. Short- and long-term
precisions were 0.32-1.16% coefficient of
variation (CV) and were within reported
values (23). A comparison ofa set ofphan-
tom readings separated by 15 months
showed a + 0.33% bias.
Blood Pb measurements. Blood drawn
into separate Becton-Dickinson blue top
trace metals vacutainer tubes (Becton-
Dickinson, Franklin Lakes, NJ) containing
EDTA was refrigerated at 2-8°C. Analysis
was performed by graphite furnace atomic
absorption spectrophotometry with Zeeman
background correction on a Perkin-Elmer
Model 3030Z with an HGA 600 furnace
(Perkin-Elmer, Norwalk, CT) (24). Sample
transfer tubes and reagent glass or plas-
ticware were acid-washed prior to use.
Preparatory work was performed in a high-
efficiency particulate air (HEPA)-filtered
class 10,000 clean space. All six samples on
the same person were performed within the
same run. Samples were prepared in dupli-
cate and each duplicate was analyzed twice.
Quadruplicate results were averaged. Intra-
assay precision was 6% (CV) at 2.0 jig/dl.
Accuracy was maintained by participation in
the College of American Pathologists/
American Association of Clinical Chemists
Blood Lead Survey approved by the
Occupational Safety and Health Admini-
stration and by the use ofassayed proficien-
cytest samples as calibrators.
Other bloodandserum measurements.
Hemoglobin, albumin, and iron measure-
ments were performed in the hospital clini-
cal laboratory by standard methods.
Osteocalcin (NovoCalcin, Metra Biosystems
Inc., Mountain View, CA) and bone-specif-
ic alkaline phosphatase (ALKPHASE-B,
Metra Biosystems Inc.) measurements in
serum at 2 weeks and 6 months were deter-
mined at the University of California San
Francisco Calcitrophic Hormone Reference
Laboratory. After phlebotomy, specimen
Table 1. Descriptive variables ofthe study group and the incomplete group
Variable (units)
Age atdelivery (years)
Ethnicity (% Hispanic)
Time living in the United States (years)
Years of education (years)
Proportion in WIC (%)
Monthly rent perfamily (dollars)
Number of rooms in home (n)
Number ofadults living at home (n)
Number ofadults employed (n)
Within-cohort socioeconomic rating (Z-score)
Having ever smoked (%)
Having ever drank alcohol (%)
Having ever used illicit drugs (%)
Health rating (zscore)
Gravidity (n)
Time since lastdeliveryb(days)
Number ofliving children (n)
Number of prenatal visits (n)
Prenatal weight(Ib)
Proportion having spontaneous vaginal delivery (%)
Neonatal birth weight(g)
Time in hospital after delivery (days)
Prenatal serum albumin (g/did)
Prenatal serum iron (pg/did)
Prenatal hemoglobin (g/did)
Using prenatal iron supplements (%)
Using calcium supplements during lactation (%)
Calcium intake rating (score units)
Dietary quality rating (score units)
Bone density atfemoral neck(g/cm2)
Bone density atvertebral spine (g/cm2)
Study group (n= 58)
Mean ± SD
25.6 ± 6.6
81.0
8.4± 10.0
9.8 ± 3.1
87.9
607 ± 307
3.6 ± 1.5
3.0 ± 1.3
1.7 ± 1.1
0.07 ± 0.72
19.0
49.0
6.9
0.00 ± 1.07
2.6 ± 1.6
1333 ± 1090
1.0 ± 1.3
11.3 ± 3.6
164 ± 32
79.3
3515± 450
1.5 ± 0.8
3.2 ± 0.2
94 ± 59
14.0 ± 5.9
15.5
5.2
3.6 ± 1.2
2.6 ± 0.7
0.97 ± 0.13
1.11 ± 0.12
Incompletes (n= 43)
Mean ± SD
26.7 ± 5.7
76.7
8.3 ± 9.1
10.2 ± 3.3
86.0
585 ± 305
3.7 ± 2.8
3.7 ± 2.1
1.9 ± 1.3
-0.03 ± 0.55
45.2a
59.0
16.3
0.04 ± 0.96
2.4 ± 1.7
1708 ± 1385
0.7 ± 1.2
12.Oc ± 2.3
170 34
76.7
3426C + 474
1.9c + 1.3
3.2 ± 0.2
89 ± 52
13.9c + 5.7
18.6
9.3
3.6 ± 1.6
2.9 ± 0.7
0.97c+ 0.11
1.17c + 0.16
tubes were placed immediately in an
insulated cool pouch and were centrifuged
and separated into serum within 1 hr.
These were then stored at -20°C until
analysis. All samples were run as paired
specimens and processed in duplicate. Both
assays are enzyme-linked immunosorbent
assays having intra-assay CVs of 4.6 and
7.6%, respectively.
Dataprocessing and statistical meth-
od. All data were entered into predefined
template forms on a laptop computer
(interview, chart review histories, routine
laboratory data, and bone density measure-
ments) and were managed by Epi Info soft-
ware Version 6 (Centers for Disease
Control and Prevention, Atlanta, GA).
Initial errors and completeness were
checked with this program. Data were
transferred to Statistical Analysis Systems
software (SAS Institute, Inc., Cary, NC)
for subsequent analysis. Error checking was
then performed manually and random spot
checking was performed against original
sources when available.
All variable distributions were reviewed
for normality and only blood Pb concen-
trations required logarithmic transforma-
tion. Other descriptive statistics were com-
puted as means and standard deviations.
Comparisons between incompleted and
completed study subjects were performed
on prepartum data by t-test or chi-square
test. The determination of randomness of
incompletion was performed by comparing
means of the sequentially assigned subject
number. Validity ofthe study design (lacta-
tion-related bone densitychanges) was con-
firmed by comparing the mean change in
bone densities for subjects breast-feeding at
6 months to those quitting before 6
months, as in Sowers et al. (13). In addi-
tion, the validity of the design was exam-
ined using multiple regression analysis of
the change in bone densities as influenced
by breast-feeding frequency and other
independent variables.
Percentage changes in blood Pb con-
centrations over postpartum time intervals
were examined by multiple regression
analysis with respect to percentage changes
in bone densities and other possible inde-
pendent variables. Also, integrated blood
Pb concentrations were computed over the
2-week to 6-month period and used as the
outcome variable in place ofthe percentage
change in blood Pb and then examined
similarly. As little as 15% (R2 of>0.15) of
the variability in the relationship between
the percentage changes in bone density and
percentage changes in blood Pb could be
detected by this analysis, when n = 58, a =
0.05, and ,B =0.80. Given the sample size,
mean, and standard deviations ofthe blood
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Abbreviations: SD, standard deviation; WIC, Well Infant Child Program.
ap<0.05, chi-square test.
bMean days since last deliveryforthose having previous pregnancy.
cn<43; not all incomplete subjects reached this stage.
dTo convert serum albumin from g/dl to g/l multiply by 10; to convert serum iron from pg/dl to pmol/l multiplyby0.179; to convert blood hemo-
globin from g/dl to g/l multiply by 10.
-
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Table2. Outcome variables forthe study group during lactation
Geometric
Variable (units) Mean ± SD mean
Weight change (from enrollmentto 6 months postpartum) (%)
Percent ofgroup still breast-feeding at:
2weeks(%)
6weeks(%)
3 months (%)
6 months(%)
Reported daily breast-feedingsb at
2weeks (n)
6weeks (n)
3 months (n)
6 months (n)
Total number ofbreast-feedingsb over6months(n)
Osteocalcin concentrations at:
2weeks(pg/I)
6 months(pg/I)
BSAP concentrations at:
2weeks (U/I)
6 months (U/I)
Vertebral spine bone density at:
Delivery(g/cm2)
6 months (g/cm2)
Femoral neck bone density at:
Delivery (g/cm2)
6 months (g/cm2)
Percentchange in vertebral spine bone density (%)
Percentchange infemoral neck bone density (%)
Serum albumin concentrationsc at:
Enrollment(g/dl)
Delivery(g/dl)
2weeks (g/dl)
6weeks (g/dl)
3 months (g/di)
6 months (g/dl)
Blood Pb concentrationsc at:
Enrollment(pg/dI)
1 day postpartum (pg/dl)
2weeks(pg/dI)
6weeks(pg/dI)
3 months (pg/dl)
6 months (pg/dI)
Percent change in blood Pb concentrations
atthefollowing intervals:
Enrollmentto 1 day postpartum (%)
Enrollmentto 2weeks postpartum (%)
2weeksto 6weeks postpartum (%)
2weeksto 6 months postpartum (%)
6weeksto 6 months postpartum (%)
Integrated blood Pb concentrations from 2weeks
to 6months postpartumdl(pg x day)Vdi]
-11.58±72 -
91.4
85.2
82.5
63.8
9.4 ± 3.3
7.9 ± 2.2
6.4 ± 2.2
5.5 ± 2.4
1002 ± 537
4.5 ± 3.3
9.5 ± 5.3
15.6 ± 5.2
17.6 ± 7.8
1.11 ± 0.12
1.08 ± 0.11
0.97 ± 0.13
0.96±0.14
-2.46a ±6.33
-0.67 ± 5.21
3.2 ± 0.2
2.6 ± 0.4
4.0 ± 0.2
4.3 ± 0.2
4.3 ± 0.3
4.3 ± 0.3
2.35 ± 2.05
2.03 ± 2.07
2.52 ± 2.18
2.64 ± 1.96
2.51 ± 1.85
2.33 ± 1.63
-15.0a ± 24.0
13.08 ±31.1
8.98 ± 28.3
3.5 ± 55.1
-5.2 ± 47.7
-17.23 ± 260.9
Abbreviations: SD, standard deviation; Pb, lead; BSAP, bone-specific alkaline phosphatase.
'Significant paired change atp<0.05, paired t-test.
binclusive ofequivalentbreast-pump feedings.
'To convertserum albumin from g/dl tog9i multiply by 10;to convertblood Pbfrom pg/dl to pmoVl mulfiply by0.0483.
'Values indicate pg/dl x days above orbelowbaseline blood Pbvalue at2weeks.
Pb concentrations, the minimum mean
detectable change in blood Pb concentra-
tions between any two time points was
0.02gmol/l (0.4 pg/dl).
Results
The study subjects were primarily Hispanic
immigrants, noncollege-educated, healthy,
andofpooreconomic status. Descriptive sta-
tistics of the incompleted and completed
study subjects are given in Table 1 as
obtained by interview questionnaire and
chart review. There were no differences
between the studygroup and the incomplete
group except for recall of having ever
smoked. No subject reported smoking dur-
ing pregnancy or lactation. Occurrence of
incompletion was random. The childbirth
andperipartumvariables listed inTable 1 are
typical ofthepopulation seenattheNMS.
Table 2 shows the important outcome
variables during lactation. The average
subject was estimated to have 1,002 breast-
feedingepisodes. As expected, the percentage
ofsubjects breast-feeding and the number
ofbreast-feedings per day steadily dimin-
ished as the postpartum periods progressed.
At the end of the study, 63.8% were still
breast-feeding. Table 2 shows the mean
blood Pb concentrations ofstudysubjects at
each interview time point. Blood Pb con-
centrations were similar to local population
values. For the study subjects, the blood Pb
concentrations demonstrated a significant
15% decrease from the prepartum appoint-
ment date to the delivery day, a 13%
increase from the prepartum appointment
to the 2-week postpartum date, and a fur-
ther 8.9% increase from the 2-week date to
6 weeks postpartum (Table 2). Only an
additional 0.3% increase (not significant)
was seen from 6 weeks to 3 months. There
were no significant changes in paired blood
Pb concentrations over the intervals from 2
or 6 weeks to 6 months postpartum for the
cohort. Figure 1 shows the temporal corre-
spondence ofthe changes in blood Pb and
the changes in serumalbumin.
Study validation. Overall, the entire
group showed a significant decrease in the
bone density in the vertebral spine (2.46 ±
6.33%), but not in the femoral neck.
Osteocalcin and bone-specific alkaline
phosphatase concentrations tended to be
modestly higher at the 6-month versus the
2-week time point (Table 2). Changes in
the bonedensityofthevertebral spine tend-
ed to be greater in those subjects still breast-
feeding at 6 months (3.04 ± 6.93%, n = 36)
than in those breast-feeding less than 6
months (n = 22), as can be seen in Table 3.
Femoral neck bone density changes also
tended to be greater in the subjects breast-
feeding through 6 months than in the sub-
jects with lesser amounts ofbreast-feeding,
though also not statisticallysignificant.
The relationship between bone densities
at delivery and at 6 months was expected to
be strong (simple i2 = 0.6550, p = 0.0001),
with breast-feeding frequency accounting for
an extra 12% ofthevariability (multiple R2 =
0.7799, p = 0.0001) and the other variables
(age, weightchange, gravidity, time sincelast
delivery, initial serum iron concentration,
calcium intake ratng, dietary quality rating,
initial hemoglobin concentration, andhealth
rating) not contributing significantly. Thus,
the determinants ofthe final bone density in
the vertebral spine were the initial bone den-
sityandbreast-feeding frequency. The analo-
gous relationships for the bone densities of
the femoral neck with breast-feeding fre-
quencywere i2 = 0.8673,p = 0.0001, andX?2
= 0.9094,p = 0.0001, respectively. Although
breast-feeding intensity was a significant
independent variable, its impact in the
femoral sitewas less (accountingforonly4%
additionalvariability).
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Outcome relationships. The percentage
change in blood Pb concentrations across
the meaningful period of lactation (i.e.,
from either 2 weeks to 6 months or 6 weeks
to 6 months) was not related to percentage
changes in bone densities (either vertebral
spine or femoral neck) when tested by sim-
ple regression or after multiple regression
including the following additional variables:
age, percentage weight change, gravidity,
average serum iron concentration, socioeco-
nomic rating, calcium intake rating, calorie
intake rating, years in the United States,
and percentage change in serum albumin
concentration for the same period (Table
4). Using the blood Pb concentration at
either 2 or 6 weeks to predict the concen-
trations at 6 months showed an expected
significant regression (e.g., blood Pb from 6
weeks and 6 months, r2 = 0.6495 as simple
regression), but also without impact from
other listed variables including the change
in bone densities when examined by mul-
tiple regression (R2 = 0.6718). Multiple
regression of the integrated blood Pb from
2 weeks to 6 months with the same inde-
pendent variables showed that only weight
change was significant (Table 4).
Discussion
This study demonstrates no observable
change in blood Pb concentrations from 2
or 6 weeks to 6 months postpartum and no
relationship between the change in bone
densities and the change in blood Pb con-
centrations during lactation. Thus, it is
unlikely that measurable effects would
result from Pb released from bone due to
lactation at these low (well within popula-
tion norms) blood Pb concentrations. The
study also confirms that changes in bone
density do occur during lactation and are
related to breast-feeding frequency.
This study was modeled in part after
the investigation of Sowers et al. (13), in
which changes in bone density ofapproxi-
mately 5% were seen in lactation periods of
up to 5-6 months. Our study showed
slightly less bone density losses over 6
months and showed the same ordered mag-
nitudes at vertebral spine and femoral neck
sites. We attempted to improve upon that
study by encouraging breast-feeding in all
subjects, by using a more dynamic account
ofbreast-feeding, and by focusing on a rel-
atively homogeneous population (similar
socioeconomic, ethnic, educational, and
health backgrounds) cared for by a single
service. The results showed that both the
continuous measure of breast-feeding fre-
quency and the dichotomous measure of
greater or less than 6 months of lactation
were predictors of bone losses. We had
considered that this population ofsubjects
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Figure 1. Geometric mean blood lead (Pb) and mean serum albumin concentrations during the postpartum
lactation period. Subjects breast-feeding >6 months (n = 36); subjects breast-feeding <6 months (n = 20).
Standard deviations are in Table 2. To convert blood Pb in pg/dl to pmol/l multiply by 0.0483; to convert
serum albumin in g/dl to g/l multiply by 10.
Table 3. Bone density changes during lactation
Change in bone density (%)
Vertebral spine Femoral neck
n Mean SD Mean SD
Breast-feeding through 6 months 36 -3.03a 6.93 -1.27 5.50
Breast-feeding <6 months 20 -1.49 5.18 +0.41 4.58
SD, standard deviation.
&Significant change atp<0.05, paired t-test
Table 4. Changes in blood lead (Pb) concentrations during lactation as a function of changes in bone
density and other independentvariables
Multiple regressionab Significant
Relation p R2 variablesc
Percentchange in blood Pb concentrations from 2weeks
to 6 months postpartum
Vertebral spine 0.7138 0.1565 None
Femoral neck 0.7381 0.1547 None
Percent change in blood Pb concentrations from 6weeks
to 6 months postpartum
Vertebral spine 0.8689 0.1167 None
Femoral neck 0.9054 0.1079 None
Integrated Blood Pb from 2weeksto 6 months postpartum
Vertebral spine 0.4262 0.1433 Weightchange
Femoral neck 0.3738 0.1563 None
&Independent variablestested in multiple regression include: Percentage change in eithervertebral spine orfemoral neck bone density, age,
percentage weightchange, gravidity, initial blood Pb, socioeconomic rating, calcium intake rating, caloric intake rating, average serum iron
concentration, years in the United States, or change in serum albumin concentration overthe same interval.
bMultiple regression relationships between final blood Pb concentration and initial blood Pb concentrations were alsotested and notmade
more precise bythe inclusion ofthe change in bone density or any othervariable and are notlisted here (seetext).
cAnyvariable, including changes in bone densities, accounting forsignificantvariability(p<0.05) inthe dependentvariable, eithertype or
type Ill sums ofsquares.
might also show greater bone losses than in
the model study and might have higher
blood Pb concentrations than the general
population because subjects were economi-
cally poor and did not take calcium supple-
ments. However, neither enhancement was
observed. Subsequently, kinetic studies by
Specker et al. (25) and a prospective study
by Kalkwarf et al. (26) showed that the
mobilization of bone calcium during lac-
tation is little affected by supplemental
calcium intakes.
Younger age (<18 years) (27), greater
gravidity or parity (28,29), lower calcium
intake (25,27,28), and shorter interpregnan-
cy intervals (30,31) have inconsistently been
associated with bone density losses. None
were significant factors in our regression
analysis of changes in bone density as a
function of breast-feeding intensity and
other variables. This may be due to the
small sample size ofthis study, a lack ofany
relationship, and possibly in part due to the
greater precision ofbreast-feeding estimates
Environmental Health Perspectives * Volume 107, Number 3, March 1999 191Articles * Osterloh and Kelly
herein and the resulting improved power at
explaining remainingvariability.
Blood Pb concentrations during breast-
feeding did not change for the periods
beyond 2 or 6 weeks postpartum and there
was no association with changes in bone
density. The integrated blood Pb concen-
trations from 2 weeks to 6 months were
calculated as a possible more powerful mea-
sure of blood Pb increase or decrease over
the entire period, in contrast to the change
in blood Pb between two time points. The
baseline for this calculated curve area was
the 2-week blood Pb concentration chosen
in part to reflect blood Pb less impacted by
plasma volume changes. Whatever the
blood Pb time point chosen for the base-
line, the curve areas will have a similar
absolute variation, but for a baseline at 2
weeks there will be less bias and greater
dynamic range. The resulting integrated
blood Pb concentrations were highly vari-
able and showed no relationship to change
in bone density.
Although bone loss was hypothesized to
be the major determinant ofany identified
change in blood Pb concentration, other
factors that might affect a change in blood
Pb concentrations were also considered.
These factors included age, weight change,
gravidity, initial blood Pb, estimate of cal-
cium intake, average serum iron concentra-
tions, socioeconomic rating, years living in
the United States, and changes in blood
volume (as represented by the percentage
change in serum albumin over the exam-
ined intervals). Age, sex, socioeconomic
status, and some other variables can be
determinants ofblood and bone lead accu-
mulation over a lifetime (14,32). The
impact of such variables in this study
would be limited because ofthe short dura-
tion of the study and would tend to influ-
ence initial levels rather than the change
over 6 months. Also, age and socioeconom-
ic rating were unlikely to be powerful inde-
pendent variables for changes in blood Pb
because each was narrowly distributed in
this cohort. Similarly, the amounts of
mobilizable bone Pb present at the begin-
ning of the study period may relate to the
magnitude of the change in blood Pb as
suggested from anecdotal case reports of
higher Pb exposures (see below). Thus, a
greater number ofbirths may deplete initial
bone stores. Also, blood Pb, a poor corre-
late of bone Pb, may vary loosely with ini-
tial mobilizable stores. Therefore, gravidity
and initial blood Pb concentration were
also included as independent variables,
although potential interactions with each
other or age may have required further
analysis. However, neither were significant
independent variables in the analysis.
Adequate calcium intake will reduce
dietary Pb absorption as compared to defi-
cient intakes in animal studies (33,34).
Thus, a measure of calcium intake may
independently predict blood Pb accumula-
tion from dietary sources during the lacta-
tional period. On the other hand, variation
in calcium intake is not thought to be a pre-
dictor of Pb mobilization from bone per se
because calcium intake during lactation had
neither altered calcium loss from bone in
humans (25,28) nor increased the mobiliza-
tion of Pb during lactation in animal stud-
ies (8). Most subjects had a reasonable
dietary intake of dairy products, though
only a few were ingesting additional supple-
mental calcium tablets. However, dietary
estimates of calcium intake are notorious
for their imprecision and are weighted
heavily toward historical recall of dairy
products (18). Given this information and
the limited extent to which calcium intake
was queried, an effect of this variable was
also unlikely. Average serum iron concen-
trations were used as a measure ofadequate
iron intake, which also can reduce dietary
absorption ofPb (35).
Changes in serum albumin over the
same periods (as for changes in blood Pb)
were used as a surrogate independent vari-
able to account for both plasmavolume and
hematocrit changes. Tissue mass and body
water increase in rough proportion during
pregnancy, but there is a slight excess of
increased body water. Along with an iron-
limited decrease in erythropoiesis during
pregnancy, this results in a 15% decrease in
hematocrit by the 34th week ofpregnancy,
which is maintained until delivery. Much of
this dilution and lowered hematocrit is sub-
stantially recovered by 4 weeks postpartum
(36-38). Use ofalbumin as a surrogate was
chosen in this study because hematocrit or
hemoglobin were collected only at initial
time points and because albumin varies
similarly. The need to account for plasma
volume changes is clear because 95% ofthe
Pb resides within the red blood cell. This is
apparent in Figure 1, where the changes in
albumin concentration were trended in the
same direction as the changes in blood Pb
for each period where the volume changes
were most dramatic (enrollment to delivery,
and delivery to 2 weeks postdelivery).
In post hoc analysis, these peripartum
intervals known to be affected by changes
in fluid volume were also examined. During
the period between 2 and 6 weeks, the per-
centage change in blood Pb was significant-
ly regressed with the percentage changes in
the vertebral bone density (p = 0.0103 for
the model, p = 0.0466 for vertebral bone),
but not changes in femoral bone density.
However, most of the variability in this
multiple regression was accounted for by
the percentage change in albumin (p =
0.0096) over the same interval. This regres-
sion has limited biologic or logical meaning
because there is no temporal relation
between the prediction of short-term
changes in blood Pb (over 4 weeks) by
long-term changes in bone density (6
months). One possible interpretation may
be that early lactational stimuli are pro-
nounced and measurable mobilization had
in fact occurred. Yet measurable bone losses
by bone densitometry are nlot detectable for
such short durations (13). Because of the
strong impact of the changing plasma vol-
ume surrogate, this observation must have a
conservative interpretation.
The data collection time points in this
study were chosen for several reasons. The
6-month measurements were selected as the
time previously demonstrated where bone
losses were maximal as measured by dual-
energy x-ray densitometry (13). The initial
bone density measurements were made
within 1-day postpartum for most subjects
because individuals were already in the hos-
pital near the instrument. Prepartum bone
density determinations were not performed
to avoid concern over fetal radiation expo-
sure, which would have been extremely low,
although the perception of the subjects
would probably have affected recruitment.
Osteocalcin and bone-specific alkaline
phosphatase at 2 weeks and 6 months were
measured in an attempt to add further con-
firmation regarding increasing bone activity
(39). Limitation in expenses and utility of
these markers led to the decision to mea-
sure these only toward the beginning and
end ofthe study. Thus, neither peak activi-
ty nor maximum change in activity due to
lactation were necessarily assessed.
Sampling time points for blood Pb con-
centrations were spaced to find a baseline
sampling time less affected by the afore-
mentioned acute postpartum physiologic
changes in body mass and blood volume. In
the only prior study of blood lead changes
during the lactational period (15), conclu-
sions about changes during lactation were
limited because of the small amount of
breast-feeding that occurred (25% of the
subjects breast-fed and only 8% fed longer
than 4 months), the lack of confirmatory
bone mass measurements, and the poor
choice of blood Pb sampling time at the
delivery date. Peripartum blood Pb concen-
trations are hemodiluted due to the afore-
mentioned volume changes of pregnancy
and decreased erythropoeisis. Later postpar-
tum concentrations are likely to show less-
ening degrees ofhemodilution. In addition,
in some cases blood Pb concentrations are
likely to be diluted further at delivery by
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intravenous fluid replacement that is often
provided. Our data show that blood Pb
concentrations had decreased by the first
dayafter delivery as compared to prepartum
values by 15.0%. By 2 weeks postpartum,
blood Pb concentrations have regained and
surpassed the pre- and peripartum hemodi-
luted concentrations. An appropriate sam-
pling time to observe changes in blood Pb
due to lactational influences would not be
the delivery date used in the earlier study,
but after some equilibration such as the 2-
or 6-week postpartum sampling times avail-
able in this study. Also, all these same inter-
vals were used as convenient interview times
for questions directed at assessing breast-
feeding intensity.
Previous information in humans on the
possible mobilization ofPb from bone due
to various conditions is mostly anecdotal or
cross-sectional, but is occasionally convinc-
ing in case reports ofhigher body Pb bur-
dens during pathophysiologic states that
cause increased bone turnover (11,12).
That blood Pb may be influenced by hor-
monal factors affecting bone turnover has
been observed by measuring a decrease in
blood Pb concentrations in hyperparathy-
roid subjects after becoming euparathyroid
(7). Also, cross-sectional studies and one
prospective study on Pb mobilization dur-
ing pregnancy have shown slight increases
in blood Pb during the third trimester
(6,40), although levels tended not to exceed
first-trimester blood Pb concentrations.
Recently, Gulson et al. (41) showed that
isotopically distinct bone sources ofPb con-
tributed to blood Pb in immigrants who
acquired the local prevalent blood isotopic
composition during their pregnancies,
although actual blood Pb concentrations
onlyincreasedslightlyandvariably.
One case report of elevated blood Pb
concentrations during breast-feeding in a
woman with past occupational exposure to
Pb is documented (42). Baseline blood Pb
concentrations in this case were approxi-
mately 15 times greater than in our cohort,
so these greater amounts of Pb recently
deposited in bone may have allowed easier
detection. However, blood Pb concentra-
tions only slightly exceeded prepartum con-
centrations and peripartum hemodilution
may have been a factor in properly inter-
preting that observation. Animal studies
have demonstrated that after long-term oral
intake, Pb can be mobilized from bone dur-
ing lactation (8,43) with three significant
differences from the human condition:
doses and tissue concentrations were many-
fold higher; rodents tend to mobilize larger
amounts of bone than humans; and dis-
continuation of high Pb intakes just prior
to lactation or continuation of exposure
during lactation is likely to result in mobi-
lization ofrecently deposited Pb, whereas if
the Pb were deposited in the distant past or
nonhomogeneously, mobilization of Pb
maybe less likely.
Using blood Pb as a measure of Pb
released from bone may have limitations in
our study and in all such investigations.
Because ofthe low concentrations currently
prevalent in U.S. populations ofchild-bear-
ing age, measurement of real change in
blood Pb is difficult because of analytical
and biologic variability. Although strategies
such as quadruplicate blood Pb analysis,
same-run analysis ofall samples from a sub-
ject, and the use ofa homogeneous popula-
tion from one section ofSan Francisco were
aimed at reducing analytical and biologic
variability, a minimum change of only 0.4
pg/dl would have been detectable in this
cohort size. Yet, while this represents a rela-
tively large change as compared to starting
concentrations, it does demonstrate that
serious elevations in blood Pb are not
occurring in lactating populations with the
currently low blood Pb concentrations.
Another limitation to using blood Pb as an
end point is the dilutional effect of tissues
(other than blood) on Pb released from
bone. Tissue volumes and tissue Pb concen-
trations are larger than the blood Pb pool
and may take up much of the released Pb.
At higher bone concentrations of Pb or a
with more recent exposure on a background
of lowered contemporary blood Pb, such
mobilization may be detectable.
Whether Pb may be released in some
proportion to calcium loss from bone is
unclear. Although Pb follows calcium into
bone, Pb salt dissolution constants are
much poorer than calcium salts, so less may
be released under osteoclastic influences
(acid dissolution). This may be the inher-
ent reason underlying the observations that
Pb accumulates in bone relative to calcium
throughout life. On the other hand, a
cross-sectional autopsy study of bone Pb
analysis by age showed that after the sixth
decade of life Pb no longer accumulated,
but that the amount ofPb ratioed to calci-
um (mineral or ash) tended to decrease in
trabecular bone, suggesting disproportion-
ately greater loss ofPb than calcium during
those years ofaging and osteoporosis (44).
However, possible secular periods of past
exposure make these data difficult to inter-
pret with respect to kinetic processes,
although they are consistent with current
thought by many investigators regarding
Pb mobilization. Given that bone con-
tributes a sizeable proportion of the Pb in
the blood compartment during low envi-
ronmental exposure (4,41), it may be that
the relatively slight increases in resorption
seen in various pathophysiologic states may
not be that much greater than the already
high baseline contributions. This would
suggest that the mechanism for calcium
availability during lactation is reduced
deposition, which is consistent with both
the noted lack ofeffect of calcium supple-
mentation on bone density during lactation
(25,26) and with the suppression ofcalcium
urinary losses during lactation (28).
No actual assessment ofchanging exter-
nal environmental Pb exposures was feasible
in this study. Therefore, low levels ofexpo-
sure to Pb for any subject may not have
been at a steady state during the course of
the study. For instance, a few subjects
changed their living quarters during the
study, but did so within the same section of
the city. Still, different background Pb
exposures may have resulted and may have
varied enough to increase or decrease base-
line blood Pb concentrations. Whereas
individual circumstances would average,
seasonal or broad environmental trends
might bias the measured change in blood
Pb. Other limitations indude the previously
stated power limitations, the prevalence of
low blood Pb concentrations, the limited
impact of the other independent variables
examined, and the limited ability to detect
nonlinear relationships. Also, the generaliz-
ability of this study is confined, in that
other populations ofdifferent ethnicity, cir-
cumstance, or bone Pb stores (large past
exposures) may behave differently. This
study only demonstrates that serious eleva-
tions in blood Pb concentrations do not
occur as a result oflactation.
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